CD30-directed Immunoconjugate [EPC]

1 drugs in this class with 9,949 total adverse event reports.

1 Drugs
9,949 Total Reports
5,955 Serious Reports
1,881 Death Reports
# Drug Name Generic Name Reports Serious Deaths
1 Brentuximab Vedotin BRENTUXIMAB VEDOTIN 9,949 5,955 1,881